Education
About Us
Working with TipRanks
Follow Us
Pfizer Inc (PFE)
:PFE
PFE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$20.92 - $31.54
Previous CloseN/A
Volume12.20M
Average Volume (3M)60.12M
Market Cap
$129.99B
Enterprise Value$198.11B
Total Cash (Recent Filing)$2.18B
Total Debt (Recent Filing)$44.17B
Price to Earnings (P/E)16.2
Beta0.27
Next Earnings
Apr 29, 2025EPS Estimate
0.67Next Dividend Ex-Date
May 09, 2025Dividend Yield7.42%
Share Statistics
EPS (TTM)1.41
Shares Outstanding5,671,454,600
10 Day Avg. Volume48,678,344
30 Day Avg. Volume60,122,727
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)N/A
Price to Sales (P/S)2.34
Price to Cash Flow (P/CF)5.50
P/FCF Ratio5.00
Enterprise Value/Market Cap1.52
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.20
Enterprise Value/Ebitda10.93
Forecast
1Y Price Target
$27.80Price Target Upside21.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
---
Bulls Say, Bears Say
Bulls Say
Financial PerformancePfizer's current P/E ratio and high dividend yield are expected to provide some support for the share price.
Market GrowthEx-US markets could see growth with Eliquis and other vaccines, driven by continued share gains and strong launches.
Product DemandStrong demand growth for US Eliquis is expected to offset pricing headwinds and previous quarter stocking issues.
Bears Say
Dividend ConcernsInvestors have concerns about the sustainability of Pfizer's nearly ~8% dividend yield, which is the industry's highest.
Product DiscontinuationPfizer is discontinuing the drug Danuglipron due to a potential liver injury case, which is seen as a setback for the company's opportunity in obesity.
Regulatory ImpactThe Medicare Part D redesign is anticipated to have an unfavorable impact on Pfizer.
---
Ownership Overview
0.03% Insiders
17.10% Mutual Funds
0.73% Other Institutional Investors
60.43% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PFE FAQ
What was Pfizer Inc’s price range in the past 12 months?
Pfizer Inc lowest stock price was $20.91 and its highest was $31.54 in the past 12 months.
What is Pfizer Inc’s market cap?
Pfizer Inc’s market cap is $129.99B.
When is Pfizer Inc’s upcoming earnings report date?
Pfizer Inc’s upcoming earnings report date is Apr 29, 2025 which is in 3 days.
How were Pfizer Inc’s earnings last quarter?
Pfizer Inc released its earnings results on Feb 04, 2025. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.472 by $0.158.
Is Pfizer Inc overvalued?
According to Wall Street analysts Pfizer Inc’s price is currently Undervalued.
Does Pfizer Inc pay dividends?
Pfizer Inc pays a Quarterly dividend of $0.43 which represents an annual dividend yield of 7.42%. See more information on Pfizer Inc dividends here
What is Pfizer Inc’s EPS estimate?
Pfizer Inc’s EPS estimate is 0.67.
How many shares outstanding does Pfizer Inc have?
Pfizer Inc has 5,671,454,600 shares outstanding.
What happened to Pfizer Inc’s price movement after its last earnings report?
Pfizer Inc reported an EPS of $0.63 in its last earnings report, beating expectations of $0.472. Following the earnings report the stock price went down -1.26%.
Which hedge fund is a major shareholder of Pfizer Inc?
Currently, no hedge funds are holding shares in PFE
---
Pfizer Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$27.80 (21.29% Upside)
$27.80 (21.29% Upside)
Blogger Sentiment
Bullish
PFE Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 23.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $414.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
News Sentiment
Very Bullish
Bullish news 88%
Bearish news 13%
Bearish news 13%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.57%
12-Months-Change
Fundamentals
Return on Equity
9.05%
Trailing 12-Months
Asset Growth
-5.79%
Trailing 12-Months
Company Description
Pfizer Inc
Pfizer Inc. is a leading global pharmaceutical corporation headquartered in New York City. It engages in the discovery, development, manufacture, and sale of healthcare products, with a focus on medicines and vaccines. Pfizer operates across multiple therapeutic areas, including oncology, immunology, cardiology, and neurology, and is known for its innovative research and development efforts, contributing to the advancement of healthcare worldwide.
---
PFE Company Deck
---
PFE Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Pfizer demonstrated strong financial performance and strategic progress in 2024, with significant achievements in market leadership and pipeline advancements. While there are challenges with specific products and external factors such as the IRA, the overall sentiment is positive due to the robust execution and strategic positioning for future growth.Read More>---
PFE Revenue Breakdown
47.36% Primary Care
26.17% Specialty Care
24.54% Oncology
1.80% PFIZER CENTREONE
0.13% PFIZER IGNITE
---
PFE Stock 12 Month Forecast
Average Price Target
$27.80
▲(21.29% Upside)
Technical Analysis
Best Analysts Covering PFE
1 Year
1 Year Success Rate
25/35 ratings generated profit
1 Year Average Return
+4.43%
reiterated a buy rating last month
Copying Vamil Divan's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +4.43% per trade.
---